Guest speakers

Dr. Guindon is a notable figure in bioorganic chemistry, serving as Research Director at IRCM and Full Professor at Université de Montréal. His groundbreaking research focuses on synthesizing therapeutic molecules through innovative stereoselective reactions involving free radicals, with applications ranging from antiviral agents to cardioprotective compounds. Noteworthy is his development of sialyl Lewis X (sLeX) mimetics for treating conditions like sickle-cell anemia and severe lung infections, including those associated with Covid-19. With extensive experience in both academia and industry, including leadership roles in prestigious organizations like RSC: The Academies of Arts, Humanities and Sciences of Canada, Dr. Guindon's contributions have garnered international recognition, evident through his memberships in esteemed scientific societies and numerous honors, including the Order of Canada and the Queen Elizabeth II’s Diamond Jubilee Medal.

Dr. Auclair is a distinguished bioorganic chemist renowned for her groundbreaking work in combating antibiotic resistance through innovative approaches. With a focus on addressing the escalating threat of untreatable bacterial infections, Dr. Auclair's research aims to bridge the gap in antibiotic development by proposing alternative treatments that target bacteria without traditional antibiotics. By inhibiting bacterial itaconate-degrading enzymes, her work has demonstrated the ability to sensitize bacteria to natural antimicrobials produced by mammalian macrophages, leading to significant reductions in bacterial proliferation. With a prolific academic career spanning from the University of Alberta to McGill University, Dr. Auclair holds the Canada Research Chair in Antimicrobials and Green Enzyme, showcasing her expertise and leadership in the field. Through numerous awards, patents, and over a hundred peer-reviewed publications, Dr. Auclair continues to make invaluable contributions to combating antibiotic resistance on a global scale.